Form D Explorer

Form C-U — RS BioTherapeutics, Inc.

0001665160-24-001291 · filed 2024-09-06 · via StartEngine Capital, LLC

Offering

Target: $10,000
Maximum: $1,235,000
Security type: Other
Price per security: —
Deadline: —
Oversubscription: Accepted

Issuer

Name: RS BioTherapeutics, Inc.
CIK: 1932193
Entity: Corporation
Jurisdiction: DE
Address: 157 Baltimore St. Suite 140
Cumberland, MD 21502
Phone: —

Most recent fiscal year financials

Total assets

$31,300

Cash

—

Short-term debt

$1,051,533

Long-term debt

$10,104

Revenues

—

COGS

—

Taxes paid

—

Net income

$-3,047,449

View original on SEC EDGAR.